AXCAN Pharma(AXCA)..A GUT FEELING! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXCAN Pharma(AXCA)..A GUT FEELING!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sleepman who wrote (9)	8/16/2000 11:34:57 PM
From: Biomaven	Read Replies (3) of 46

Photofrin is the only PDT on the US market, but it is very much a first generation product. The photosensitivity that Dan referred to is a significant issue, as the drug clears slowly. QLTF presumably sold the rights to Photofrin for a reason - there are a number of second generation products on the way that seem to be significantly better in a number of areas (e.g., Lutex from PCYC is water soluble, has a better frequency of excitation that enables deeper penetration and clears much more quickly). Can't believe that ursodiol will ever be a big product. All the recent articles I have read on the subject indicate that medical treatment for gallstones is a bad idea and reserved only for those few patients who cannot tolerate surgery. (I've heard of its use in rapid weight loss programs to prevent gallstones, but I doubt this is a significant market). The H. pylori treatment does sound interesting, though. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next